Our Therapies

The first and only FDA-approved
treatment for Demodex blepharitis

Financials

SEC Filings

Filing date Form Description View
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
FWP

FWP

View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
DEFA14A

Additional proxy soliciting materials - definitive

View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

 

Anchor Link for Quarterly Results

Data provided by Kaleidoscope.